<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>

    <title>
                    Pharmaceuticals and Biotech |
                            Media Room |
                        Newswire
            </title>
    <link>https://.newswire.com/</link>
    <description>Latest news from Newswire</description>

    <atom:link href="https://www.pressrelease.com/newsroom/rss/industries-pharmaceuticals-and-biotech"
        rel="self" type="application/rss+xml" />

                                    <item>
        <title>INNOPOLIS K-Startup Showcase Bridges Korean Deep-Tech and U.S. Venture Capital</title>
                    <link>https://www.pressrelease.com/news/innopolis-k-startup-showcase-bridges-korean-deep-tech-and-u-s-venture-22657633</link>
            <guid>https://www.pressrelease.com/news/innopolis-k-startup-showcase-bridges-korean-deep-tech-and-u-s-venture-22657633</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 14 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Peek Healthcare Technologies, Inc. (&#039;Peek&#039;) Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)</title>
                    <link>https://www.pressrelease.com/news/peek-healthcare-technologies-inc-peek-launches-direct-to-employer-and-22654028</link>
            <guid>https://www.pressrelease.com/news/peek-healthcare-technologies-inc-peek-launches-direct-to-employer-and-22654028</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;PeekDirect&amp;trade; Delivers Transparent and Affordable Pricing for Brand and Specialty Drugs to Reduce Prescription Costs for Employers and Patients&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 16:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections</title>
                    <link>https://www.pressrelease.com/news/belhaven-biopharma-initiates-a-pivotal-biocomparability-study-to-22654020</link>
            <guid>https://www.pressrelease.com/news/belhaven-biopharma-initiates-a-pivotal-biocomparability-study-to-22654020</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Belhaven&#039;s Investigational New Drug (IND) Application Receives FDA Authorization to Proceed&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 14:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>21st Century HealthCare, Inc. Launches Full Fuel 365: Sports Performance Brand Targeting Athletes and Fitness Market</title>
                    <link>https://www.pressrelease.com/news/21st-century-healthcare-inc-launches-full-fuel-365-sports-performance-22653997</link>
            <guid>https://www.pressrelease.com/news/21st-century-healthcare-inc-launches-full-fuel-365-sports-performance-22653997</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Established healthcare leader expands into sports nutrition sector with comprehensive performance-focused product line&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assessment 2025</title>
                    <link>https://www.pressrelease.com/news/navitas-life-sciences-named-a-major-contender-in-everest-group-22651038</link>
            <guid>https://www.pressrelease.com/news/navitas-life-sciences-named-a-major-contender-in-everest-group-22651038</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 02 Oct 2025 19:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Gay Ad Network Launches First LGBTQ+ Digital Out-of-Home Advertising Solution</title>
                    <link>https://www.pressrelease.com/news/gay-ad-network-launches-first-lgbtq-digital-out-of-home-advertising-22646319</link>
            <guid>https://www.pressrelease.com/news/gay-ad-network-launches-first-lgbtq-digital-out-of-home-advertising-22646319</guid>
                <description></description>
        <pubDate>Wed, 01 Oct 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Neurovation Labs Joins NewYorkBIO Fellows Program to Accelerate Development of Biomarker-Driven Neuromedicines and Diagnostics</title>
                    <link>https://www.pressrelease.com/news/neurovation-labs-joins-newyorkbio-fellows-program-to-accelerate-22648575</link>
            <guid>https://www.pressrelease.com/news/neurovation-labs-joins-newyorkbio-fellows-program-to-accelerate-22648575</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company to attend upcoming NewYorkBIO Innovation Summit on September 30, 2025, in New York City&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 29 Sep 2025 15:25:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Faro Wins CDISC 2025 AI Innovation Challenge for Protocol Library Solution</title>
                    <link>https://www.pressrelease.com/news/faro-wins-cdisc-2025-ai-innovation-challenge-for-protocol-library-22647080</link>
            <guid>https://www.pressrelease.com/news/faro-wins-cdisc-2025-ai-innovation-challenge-for-protocol-library-22647080</guid>
                <description></description>
        <pubDate>Mon, 29 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>DistillerSR Launches First-of-Its-Kind Agentic AI Capabilities  to Eliminate Evidence Silos and Accelerate Time to Market</title>
                    <link>https://www.pressrelease.com/news/distillersr-launches-first-of-its-kind-agentic-ai-capabilities-to-22641300</link>
            <guid>https://www.pressrelease.com/news/distillersr-launches-first-of-its-kind-agentic-ai-capabilities-to-22641300</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 17 Sep 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Rancho Biosciences Expands Leadership in Biomedical Ontology With Appointment of Dr. Jane Lomax</title>
                    <link>https://www.pressrelease.com/news/rancho-biosciences-expands-leadership-in-biomedical-ontology-with-22634787</link>
            <guid>https://www.pressrelease.com/news/rancho-biosciences-expands-leadership-in-biomedical-ontology-with-22634787</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Industry-recognized expert SciBite, &lt;/strong&gt;&lt;/i&gt;&lt;strong&gt;and Pistoia Alliance Board Member, &lt;/strong&gt;&lt;i&gt;&lt;strong&gt;joins Rancho to advance structured data solutions for life sciences innovation&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 17 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Longwood Healthcare Leaders to Host Boston CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders</title>
                    <link>https://www.pressrelease.com/news/longwood-healthcare-leaders-to-host-boston-ceo-off-the-record-22628526</link>
            <guid>https://www.pressrelease.com/news/longwood-healthcare-leaders-to-host-boston-ceo-off-the-record-22628526</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 16 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing</title>
                    <link>https://www.pressrelease.com/news/arecia-and-apprentice-io-partner-to-scale-pharmaceutical-3d-printing-22640492</link>
            <guid>https://www.pressrelease.com/news/arecia-and-apprentice-io-partner-to-scale-pharmaceutical-3d-printing-22640492</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Aprecia will use Apprentice.io&#039;s AI-powered platform to scale its innovative technology for drug delivery solutions&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 16 Sep 2025 10:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Canyon Labs Elevates Leadership to Unite Sites and Strengthen Client Partnerships</title>
                    <link>https://www.pressrelease.com/news/canyon-labs-elevates-leadership-to-unite-sites-and-strengthen-client-22637950</link>
            <guid>https://www.pressrelease.com/news/canyon-labs-elevates-leadership-to-unite-sites-and-strengthen-client-22637950</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Strategic leadership changes align with Canyon Labs&#039; vision to scale services while strengthening its commitment to customer partnerships.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 12 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PharmaNest, NIH and VCU Launch Confirmatory Retrospective Outcome Study With 1,765 Patients to Advance AI-Driven Digital Pathology in MASLD</title>
                    <link>https://www.pressrelease.com/news/pharmanest-nih-and-vcu-launch-confirmatory-outcome-study-to-advance-ai-22638379</link>
            <guid>https://www.pressrelease.com/news/pharmanest-nih-and-vcu-launch-confirmatory-outcome-study-to-advance-ai-22638379</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort)&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 11 Sep 2025 21:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment</title>
                    <link>https://www.pressrelease.com/news/moolec-science-secures-regulatory-approval-for-safflower-glaso-22638038</link>
            <guid>https://www.pressrelease.com/news/moolec-science-secures-regulatory-approval-for-safflower-glaso-22638038</guid>
                <description></description>
        <pubDate>Thu, 11 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pharma Executives Redefine IT Priorities: Five Stats Signal Urgent Tech Shift</title>
                    <link>https://www.pressrelease.com/news/pharma-executives-redefine-it-priorities-five-stats-signal-urgent-tech-22637222</link>
            <guid>https://www.pressrelease.com/news/pharma-executives-redefine-it-priorities-five-stats-signal-urgent-tech-22637222</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Black Book Research Q2-Q3 proprietary surveys reveal digital health, cybersecurity, and data platforms as the foundation of pharma&#039;s future competitiveness&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 10 Sep 2025 18:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PillSafe Launches SAFE Investment Opportunity to Advance the First Wireless Smart Prescription Bottle Technology System</title>
                    <link>https://www.pressrelease.com/news/pillsafe-launches-safe-investment-opportunity-to-advance-the-first-22634777</link>
            <guid>https://www.pressrelease.com/news/pillsafe-launches-safe-investment-opportunity-to-advance-the-first-22634777</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 09 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>DistillerSR Unveils Ready-to-Deploy EU-MDR Literature Review Workflows to Accelerate Notified Body Submissions</title>
                    <link>https://www.pressrelease.com/news/distillersr-unveils-ready-to-deploy-eu-mdr-literature-review-workflows-22634391</link>
            <guid>https://www.pressrelease.com/news/distillersr-unveils-ready-to-deploy-eu-mdr-literature-review-workflows-22634391</guid>
                <description></description>
        <pubDate>Thu, 04 Sep 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences to Hold Free Virtual Webinar Through Outsourced Pharma on USP Guidelines for Extractable and Leachable Manufacturing Risk Assessment</title>
                    <link>https://www.pressrelease.com/news/pace-life-sciences-to-hold-free-virtual-webinar-through-outsourced-22634325</link>
            <guid>https://www.pressrelease.com/news/pace-life-sciences-to-hold-free-virtual-webinar-through-outsourced-22634325</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Pace&amp;reg; expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 04 Sep 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule</title>
                    <link>https://www.pressrelease.com/news/finetech-launches-new-technology-for-njp-1200-capsule-filling-22633316</link>
            <guid>https://www.pressrelease.com/news/finetech-launches-new-technology-for-njp-1200-capsule-filling-22633316</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 04 Sep 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PLPC-DB: De-Risked Oncology Immunotherapy Asset With Global Licensing Window and STIP-NAM Framework</title>
                    <link>https://www.pressrelease.com/news/plpc-db-de-risked-oncology-immunotherapy-asset-with-global-licensing-22633315</link>
            <guid>https://www.pressrelease.com/news/plpc-db-de-risked-oncology-immunotherapy-asset-with-global-licensing-22633315</guid>
                <description></description>
        <pubDate>Wed, 03 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>ISPOR&#039;s Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project</title>
                    <link>https://www.pressrelease.com/news/ispors-oncology-and-statistical-methods-special-interest-groups-22627993</link>
            <guid>https://www.pressrelease.com/news/ispors-oncology-and-statistical-methods-special-interest-groups-22627993</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 21 Aug 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences&#039; San Germán Site Receives Positive Inspection From FDA</title>
                    <link>https://www.pressrelease.com/news/pace-life-sciences-san-germ-n-site-receives-positive-inspection-from-22627310</link>
            <guid>https://www.pressrelease.com/news/pace-life-sciences-san-germ-n-site-receives-positive-inspection-from-22627310</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company commitment to quality excellence confirmed during FDA Inspection&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 21 Aug 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval</title>
                    <link>https://www.pressrelease.com/news/belhaven-biopharma-closes-oversubscribed-series-a-to-fund-the-22626950</link>
            <guid>https://www.pressrelease.com/news/belhaven-biopharma-closes-oversubscribed-series-a-to-fund-the-22626950</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 19 Aug 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona</title>
                    <link>https://www.pressrelease.com/news/nutrishare-acquires-select-coram-r-pharmacy-assets-to-expand-services-22625290</link>
            <guid>https://www.pressrelease.com/news/nutrishare-acquires-select-coram-r-pharmacy-assets-to-expand-services-22625290</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New Arizona site represents Nutrishare&#039;s third pharmacy to support its ability to serve home TPN patients in all 50 states&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 15 Aug 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables</title>
                    <link>https://www.pressrelease.com/news/pace-life-sciences-debuts-enhanced-cgmp-manufacturing-capabilities-to-22622033</link>
            <guid>https://www.pressrelease.com/news/pace-life-sciences-debuts-enhanced-cgmp-manufacturing-capabilities-to-22622033</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company Reopens State-of-the-Art Isolated Vial Filling Line at Aseptic Fill-Finish Center of Excellence&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 12 Aug 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Vodori Debuts on AppExchange, Modernizing Compliant Content Delivery for Life Sciences</title>
                    <link>https://www.pressrelease.com/news/vodori-debuts-on-appexchange-modernizing-compliant-content-delivery-22570309</link>
            <guid>https://www.pressrelease.com/news/vodori-debuts-on-appexchange-modernizing-compliant-content-delivery-22570309</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Vodori&#039;s app will deliver content access directly inside Salesforce, streamlining content approval-to-distribution workflows for life sciences teams seeking agility over complexity.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 12 Aug 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Behemoth Labz GLP-1 Nasal Spray Review for Researchers</title>
                    <link>https://www.pressrelease.com/news/behemoth-labz-glp-1-nasal-spray-review-for-researchers-22622053</link>
            <guid>https://www.pressrelease.com/news/behemoth-labz-glp-1-nasal-spray-review-for-researchers-22622053</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Explores Behemoth Labz GLP‑1 nasal formulation&#039;s structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic modeling.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 07 Aug 2025 23:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>ForCast Orthopedics Announces Initial Close of Series A Financing Round to Advance Novel Therapies for PJI</title>
                    <link>https://www.pressrelease.com/news/forcast-orthopedics-announces-initial-close-of-series-a-financing-22620793</link>
            <guid>https://www.pressrelease.com/news/forcast-orthopedics-announces-initial-close-of-series-a-financing-22620793</guid>
                <description></description>
        <pubDate>Tue, 05 Aug 2025 17:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform</title>
                    <link>https://www.pressrelease.com/news/sia-lbg-receives-supplemental-grant-to-expand-features-for-global-22615872</link>
            <guid>https://www.pressrelease.com/news/sia-lbg-receives-supplemental-grant-to-expand-features-for-global-22615872</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs).&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 29 Jul 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences Achieves Fourth Consecutive Positive FDA Inspection, Reinforcing Quality Commitment</title>
                    <link>https://www.pressrelease.com/news/pace-life-sciences-achieves-fourth-consecutive-positive-fda-inspection-22617008</link>
            <guid>https://www.pressrelease.com/news/pace-life-sciences-achieves-fourth-consecutive-positive-fda-inspection-22617008</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have achieved successful recent inspections&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 29 Jul 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Diorasis Therapeutics and Northway Biotech Announce Partnership for the Development and Manufacturing of AAV Gene Therapy for Glaucoma</title>
                    <link>https://www.pressrelease.com/news/diorasis-therapeutics-and-northway-biotech-announce-partnership-for-22617363</link>
            <guid>https://www.pressrelease.com/news/diorasis-therapeutics-and-northway-biotech-announce-partnership-for-22617363</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leveraging Northway Biotech&#039;s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma treatment&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 29 Jul 2025 12:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases</title>
                    <link>https://www.pressrelease.com/news/gen-and-sulfateq-bv-announce-positive-phase-1-trial-data-on-22615845</link>
            <guid>https://www.pressrelease.com/news/gen-and-sulfateq-bv-announce-positive-phase-1-trial-data-on-22615845</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable pharmacokinetic profile and high brain penetration. These findings support the advancement of SUL-238 into further clinical development for Alzheimer&#039;s and other neurodegenerative diseases.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 28 Jul 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease</title>
                    <link>https://www.pressrelease.com/news/aatec-medical-and-northway-biotech-announce-partnership-to-develop-22610507</link>
            <guid>https://www.pressrelease.com/news/aatec-medical-and-northway-biotech-announce-partnership-to-develop-22610507</guid>
                <description>&lt;ul&gt;&lt;li&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;/li&gt;&lt;/ul&gt;</description>
        <pubDate>Tue, 15 Jul 2025 07:50:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Jeff Clark&#039;s Final Vision 2025: Best Tech Stocks to Buy</title>
                    <link>https://www.pressrelease.com/news/jeff-clarks-final-vision-2025-best-tech-stocks-to-buy-22609115</link>
            <guid>https://www.pressrelease.com/news/jeff-clarks-final-vision-2025-best-tech-stocks-to-buy-22609115</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Jeff Clark&#039;s Final Vision 2025 reveals expert-vetted tech stock picks in AI, biotech, and quantum computing-built on proven options strategies, chaos pattern analysis, and actionable investment timelines for serious traders seeking growth in a volatile market.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 11 Jul 2025 23:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Canary Cure Therapeutics Unveils Breakthrough Human Cell Data for Next-Generation Obesity Therapy, CCT-217, Demonstrating Muscle-Building Fat Loss and Paving Path to Clinic</title>
                    <link>https://www.pressrelease.com/news/canary-cure-therapeutics-unveils-breakthrough-human-cell-data-for-next-22605113</link>
            <guid>https://www.pressrelease.com/news/canary-cure-therapeutics-unveils-breakthrough-human-cell-data-for-next-22605113</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Dual siRNA Therapeutic Confirms Its Robust In Vivo Results, Strongly De-Risking the Clinical Path and Underscoring CCT-217&#039;s Potential as a Transformative, Patient-Friendly Therapy for Obesity and Metabolic Disorders&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 10 Jul 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Michael Sherman, Former Chief Medical Officer of Point32Health, Joins Real Endpoints as Senior Advisor and Payer Insights Leader</title>
                    <link>https://www.pressrelease.com/news/michael-sherman-former-chief-medical-officer-of-point32health-joins-22606836</link>
            <guid>https://www.pressrelease.com/news/michael-sherman-former-chief-medical-officer-of-point32health-joins-22606836</guid>
                <description></description>
        <pubDate>Thu, 10 Jul 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences Hosts Grand Opening of Its Center of Excellence for Aseptic Fill-Finish Services in Salem, NH</title>
                    <link>https://www.pressrelease.com/news/pace-life-sciences-hosts-grand-opening-of-its-center-of-excellence-for-22602764</link>
            <guid>https://www.pressrelease.com/news/pace-life-sciences-hosts-grand-opening-of-its-center-of-excellence-for-22602764</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;July 16 Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 02 Jul 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Landmark Study in the Lancet Digital Health: Sensifai&#039;s AI Predicts Acute Systemic Inflammation With 90% Sensitivity</title>
                    <link>https://www.pressrelease.com/news/landmark-study-in-the-lancet-digital-health-sensifais-ai-predicts-22600666</link>
            <guid>https://www.pressrelease.com/news/landmark-study-in-the-lancet-digital-health-sensifais-ai-predicts-22600666</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 02 Jul 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PillSafe Taps Healthcare Veteran Lon G. von Hurwitz to Lead Brand Modernization and Commercial Strategy</title>
                    <link>https://www.pressrelease.com/news/pillsafe-taps-healthcare-veteran-lon-g-von-hurwitz-to-lead-brand-22596937</link>
            <guid>https://www.pressrelease.com/news/pillsafe-taps-healthcare-veteran-lon-g-von-hurwitz-to-lead-brand-22596937</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 25 Jun 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Multi-Institutional Team Awarded NCI Grant to Open Novel AML Trial</title>
                    <link>https://www.pressrelease.com/news/multi-institutional-team-awarded-nci-grant-to-open-novel-aml-trial-22596393</link>
            <guid>https://www.pressrelease.com/news/multi-institutional-team-awarded-nci-grant-to-open-novel-aml-trial-22596393</guid>
                <description></description>
        <pubDate>Mon, 23 Jun 2025 14:10:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Valneva Selects CliniOps as the Technology Partner for Multiple Post-Marketing Studies to Support the IXCHIQ Chikungunya Vaccination Program in Brazil</title>
                    <link>https://www.pressrelease.com/news/valneva-selects-cliniops-as-the-technology-partner-for-multiple-post-22552433</link>
            <guid>https://www.pressrelease.com/news/valneva-selects-cliniops-as-the-technology-partner-for-multiple-post-22552433</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;This collaboration underscores CliniOps&#039; continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 19 Jun 2025 15:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>HealthRX Introduces Overnight Access to Ozempic and GLP-1 Medications-No Insurance Needed</title>
                    <link>https://www.pressrelease.com/news/healthrx-introduces-overnight-access-to-ozempic-and-glp-1-medications-22594291</link>
            <guid>https://www.pressrelease.com/news/healthrx-introduces-overnight-access-to-ozempic-and-glp-1-medications-22594291</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;HealthRX&#039;s direct-access platform eliminates insurance roadblocks by offering overnight delivery of doctor-prescribed GLP-1 weight loss medications like Ozempic&amp;reg; and semaglutide-backed by licensed physicians, transparent pricing, and real results.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 18 Jun 2025 17:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Phytage Labs Debuts Urgent Liver 911 Supplement Aimed at Liver Health</title>
                    <link>https://www.pressrelease.com/news/phytage-labs-debuts-urgent-liver-911-supplement-aimed-at-liver-health-22594268</link>
            <guid>https://www.pressrelease.com/news/phytage-labs-debuts-urgent-liver-911-supplement-aimed-at-liver-health-22594268</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;23-Ingredient Liver Detox Formula Combines Science-Backed Botanicals and Antioxidants to Support Energy, Digestion, and Long-Term Liver Function in 2025&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 18 Jun 2025 15:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Lung Clear Pro Under Review: Natural Support for Deeper Breathing and Lung Health</title>
                    <link>https://www.pressrelease.com/news/lung-clear-pro-under-review-natural-support-for-deeper-breathing-and-22593867</link>
            <guid>https://www.pressrelease.com/news/lung-clear-pro-under-review-natural-support-for-deeper-breathing-and-22593867</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;A Deep Dive Into the Botanical Science, User Testimonials, and Safety Standards Behind Lung Clear Pro&#039;s Natural Respiratory Support Formula&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 18 Jun 2025 00:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare&#039;s Top Negotiated Drugs</title>
                    <link>https://www.pressrelease.com/news/i-mak-report-reveals-how-extending-patent-terms-inflate-prices-of-22591802</link>
            <guid>https://www.pressrelease.com/news/i-mak-report-reveals-how-extending-patent-terms-inflate-prices-of-22591802</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that exposes flaws in the U.S. patent system&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 16 Jun 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Gummi World Makes History: First U.S. Gummy Manufacturer to Earn Over-the-Counter Drug Certification</title>
                    <link>https://www.pressrelease.com/news/gummi-world-makes-history-first-u-s-gummy-manufacturer-to-earn-over-22591057</link>
            <guid>https://www.pressrelease.com/news/gummi-world-makes-history-first-u-s-gummy-manufacturer-to-earn-over-22591057</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Breakthrough OTC 455-4 Certification Positions Gummi World as the First Pharmaceutical-Grade Gummy Partner in the U.S.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 12 Jun 2025 16:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Powers Health Partners With Profound Research to Expand Clinical Trial Access in Northwest Indiana</title>
                    <link>https://www.pressrelease.com/news/powers-health-partners-with-profound-research-to-expand-clinical-trial-22589783</link>
            <guid>https://www.pressrelease.com/news/powers-health-partners-with-profound-research-to-expand-clinical-trial-22589783</guid>
                <description></description>
        <pubDate>Tue, 10 Jun 2025 14:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>JBA AI Earns FDA SaMD Recognition</title>
                    <link>https://www.pressrelease.com/news/jba-ai-earns-fda-samd-recognition-22554026</link>
            <guid>https://www.pressrelease.com/news/jba-ai-earns-fda-samd-recognition-22554026</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;A New Era of Accessible Health Monitoring&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 09 Jun 2025 09:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Masco Group, a Global Leader in Engineering Technologies and Services Solutions for Biopharmaceutical Manufacturing, Expands Its U.S. Presence and Process Portfolio With the Acquisition of Techniserv</title>
                    <link>https://www.pressrelease.com/news/masco-group-a-global-leader-in-engineering-technologies-and-services-22586793</link>
            <guid>https://www.pressrelease.com/news/masco-group-a-global-leader-in-engineering-technologies-and-services-22586793</guid>
                <description></description>
        <pubDate>Fri, 06 Jun 2025 13:00:00 +0000</pubDate>
    </item>
                        
</channel>
</rss>
